Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pietro Bianchini"'
Autor:
Frank Donath, Sebastian Harder, B. Parma, André Warnke, Bettina Picard-Willems, Karina Kuczka, Henning Blume, Pietro Bianchini
Publikováno v:
The Journal of Clinical Pharmacology. 48:1189-1196
Low-molecular-weight heparins (LMWHs) differ considerably in their influence on clotting tests and release of tissue factor pathway inhibitor (TFPI). Biosimilarity therefore becomes an issue when generic forms of LMWHs are developed. So far, no bioeq
Autor:
Lino Liverani, Giangiacomo Torri, Pietro Bianchini, Giuseppe Mascellani, Marco Guerrini, Franco Spelta
Publikováno v:
Carbohydrate Research. 342:835-842
Modified heparin disaccharides were obtained by the alkaline treatment of a solution containing the disulfated heparin disaccharide DeltaHexA-alpha-(1-->4)-D-GlcNSO(3),6SO(3). Their structures were characterized by one- and two-dimensional NMR spectr
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 32:44-49
Endogenous N-sulfated glycosaminoglycans (GAGs) comigrating with standard heparin and sensitive to nitrous acid treatment were isolated from plasma of healthy donors. The amount of these compounds was 7–10 µg/ml, and activated partial thromboplast
Autor:
B. Kemkes-Matthes, B. Schlott, S. Huraib, Isa Francalanci, K.J. Matthes, Pilar Casaña, E. Lafoz, C. Biosca, Akikazu Takada, Agatina Alessandrello Liotta, Francisco Martínez, Domenico Prisco, J. Al-Wakeel, N. Memon, M. Hartmann, H. Abu-Aisha, Nicoletta Zarone, Lorenzo Ji, Manuel Monreal, Rosanna Abbate, A.M.A. Gader, J. Hauptmann, José A. Páramo, G.L. Bergonzini, Pietro Bianchini, José A. Aznar, Eduardo Rocha, A.K. Al-Momen, B. Parma, J. Quiroga, K.-H. Gührs, B. Osima, Yumiko Takada, A. Corominas, B. Sangro, Tetsumei Urano, R. Galimany, Paolo Comeglio, Jolanta Malyszko, Sandra Fedi, A. Urrutia, Javier Roncales, Anna Paola Cellai, José Rifón, Felipe Prosper, Juan Ignacio Jorquera
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 25:I-V
Autor:
B. Parma, Pietro Bianchini
Publikováno v:
Arzneimittel-Forschung. 51(5)
The safety of a haemostatic and wound dressing collagen pad (Antema®) obtained from horse Achilles tendon treated with pepsin, has been studied from the immunological point of view. A sensitizing activity test and maximization test in guinea pig has
Publikováno v:
Seminars in thrombosis and hemostasis. 23(1)
The heterogeneity of unfractionated heparins (Hep) can be correlated to the species and organs of origin and to the process of production. Heparins, extracted by different, validated processes from different organs and/or tissues (mucosa, thymus, pan
Autor:
Pier Angelo Guppola, Lino Liverani, Gianluca Bergonzini, Agnese Prete, Pietro Bianchini, Giuseppe Mascellani
Publikováno v:
Thrombosis research. 74(6)
Besides the major monosulphated disaccharide sequences (IdoA-GalNAc4SO3), dermatan sulphates (DS) contain the oversulphated sequences (IdoA2SO3-GalNAc4SO3) and (IdoA-GalNAc4, 6SO3), the concentration of which is correlated with the HCII-mediated inhi
Autor:
Pietro Bianchini
Publikováno v:
Seminars in Thrombosis & Hemostasis; Jul2007, Vol. 33 Issue 5, p496-502, 7p
Autor:
F. Porciatti, Lucia Magnelli, Franca Pasquali, Simonetta Vannucchi, Pietro Bianchini, Vincenzo Chiarugi
Publikováno v:
Thrombosis Research. 49:373-383
We have studied the binding to bovine adrenal capillary endothelial cells cultured in vitro of heparin from different sources (porcine heparin Ep. 152 P, Av.M.W. 15.9 Kd and bovine heparin Ep. 756 P, Av.M.W. 12.9 Kd) and heparin fractions of various
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 802:372-377
Molecular mechanisms underlying the ability of heparin to enhance the platelet-aggregating effect of various agonists were studied. Heparin potentiates the aggregating effect of adenosine diphosphate (ADP) and epinephrine, but it is uneffective on th